Research Paper Volume 16, Issue 4 pp 3386—3403
Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on in vitro and in vivo experiments
Figure 6. The mRNA expression of P-gp and MRP6 by EM combined with DDP. (A–C) Amplification curve of P-gp, MRP6, and β-actin. (D–F) Solubility curve of P-gp, MRP6, and β-actin. (G) Relative mRNA expression of P-gp. (H) Relative mRNA expression of MRP6. All experiments were repeated three times, nsp > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.